Search Results - Galsky M
- Showing 1 - 1 results of 1
-
1
Budget Impact Of Including Avelumab As A Second-Line Treatment For Locally Advanced Or Metastatic Urothelial Cancer In The United States: Commercial And Medicare Payer Perspectives by Kongnakorn T, Bharmal M, Kearney M, Phatak H, Benedict A, Bhanegaonkar A, Galsky M
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book